NEWS
NEWS
| TICEBA RECEIVES SME ELIGIBILITY OF EMA Heidelberg, February 2012 - EMA, the European Medicines Agency, is a public register of small- and medium-sized enterprises located in London. Due to our successful registration we are now communicating openness and transparency of our information towards our customers, business partners, investors and agencies. This first step opens the dialogue with the agency in the development of medicines. Throughout the process of drug development we will be accompanied by the EMA. |
||
| NEXT EVENT: 06 - 10 March 2012, CeBIT - Centrum für Büroautomation, Informationstechnologie und Telekommunikation, Hannover (Germany). Topic: "Stammzellen aus der Haut - Neue Möglichkeiten für Vorsorge und Therapie". Booth: A50/1, Hall 8. |
||
PAST REPORTS
| TICEBA APPLIES FOR THE EXPANSION OF THE MANUFACTURING LICENSE Heidelberg, 29 July 2011 - The Life-Science Company TICEBA GmbH is filing an application for the expansion of the manufacturing license within the meaning of § 20 b and § 20 c of the German Medicines Act for the enhancement and filtration of mesenchymal pluripotent stem cells from the autologous primary cell culture as one of the first companies in Europe. TICEBA is the first private tissue bank to offer to its clients the personal and individual storage of skin tissue and the stem cells contained therein with its service "Back-up Your Life!" - as unique healthcare measure with cash value on the highest level and complying with the latest status of development in science and technology. |
||
| TICEBA NOW AT FACEBOOK Heidelberg, August 2011 - We also have dived into the Social Media Network and are presenting our company at Facebook. Just visit our official Facebook site and click "Like"! Increase our degree of popularity! |
||
